Phase I Study of Induction Chemotherapy and Concomitant Chemoradiotherapy with Irinotecan, Carboplatin, and Paclitaxel for Stage III Non-small Cell Lung Cancer

BACKGROUND: The aim of this study was to determine the maximum tolerated dose (MTD), dose limiting toxicities (DLTs), and determine the phase II dose for the combination of irinotecan-carboplatin-paclitaxel given as induction chemotherapy and with concomitant chest radiotherapy for patients with Sta...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Choong, Nicholas W., Vokes, Everett E., Haraf, Daniel J., Tothy, Peter K., Ferguson, Mark K., Kasza, Kristen, Rudin, Charles M., Hoffman, Philip C., Krauss, Stuart A., Szeto, Livia, Mauer, Ann M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2008
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3742080/
https://ncbi.nlm.nih.gov/pubmed/18166842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e31815e8566
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg